Physician profile
Lori J Packard
NPI 1750311460
$4,735.89
in general payments reported to CMS, 2019-2025
41 companies · $812 in 2025
The $812 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $367 · 2021: $873 · 2022: $1,098 · 2023: $733 · 2024: $601 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,146.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $707.31 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $472.61 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $412.06 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $347.11 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $337.45 | 2021-2025 | |
| Channel Medsystems, INC. | $248.03 | 2022-2023 | |
| Coopersurgical, INC. | $196.04 | 2020-2025 | Paragard T 380a, Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Hologic Sales and Service, LLC | $188.75 | 2021-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Myovant Sciences INC. | $181.75 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $162.24 | 2020-2022 | |
| Minerva Surgical, INC | $148.50 | 2019-2022 | |
| Therapeuticsmd, INC. | $147.75 | 2019-2022 | |
| Pfizer INC. | $134.49 | 2021-2024 | |
| Organon LLC | $88.56 | 2021-2024 | |
| Shield Therapeutics INC | $86.72 | 2023-2024 | Accrufer |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $78.84 | 2019-2022 | |
| Evofem Biosciences, INC. | $66.55 | 2021 | |
| Sage Therapeutics, LLC | $61.18 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $52.22 | 2019-2022 | |
| Agile Therapeutics, INC. | $46.68 | 2021-2023 | Twirla |
| Gynesonics, INC. | $46.42 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sanara Medtech INC. | $42.47 | 2025 | Celleraterx |
| Bayer Healthcare Pharmaceuticals INC. | $42.19 | 2019-2023 | |
| Millicent US INC | $39.96 | 2025 | Femlyv |
| Applied Medical Resources Corporation | $37.36 | 2022 | |
| Lilly USA, LLC | $36.24 | 2025 | Zepbound |
| Exact Sciences Corporation | $35.95 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $32.73 | 2022 | |
| Merck Sharp & Dohme LLC | $31.28 | 2021-2022 | |
| Convatec INC. | $25.39 | 2023 | |
| Meditrina | $24.54 | 2024 | |
| Amgen INC. | $24.18 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $21.91 | 2025 | Qelbree |
| Ethicon US, LLC | $21.49 | 2019 | |
| Smith+Nephew, INC. | $20.17 | 2025 | Stravix |
| Optumhealth Care Solutions, LLC | $17.82 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Si-Bone, INC. | $16.57 | 2020 | |
| Lupin INC. | $15.17 | 2020 | |
| Duchesnay USA Incorporated | $14.24 | 2019 | |
| Currax Pharmaceuticals LLC | $13.99 | 2024 | Contrave |
| Nalpropion Pharmaceuticals LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Packard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.